141 related articles for article (PubMed ID: 4910537)
21. Further studies regarding the question of cellular immunity in mouse typhoid.
Rowley D; Auzins I; Jenkin CR
Aust J Exp Biol Med Sci; 1968 Aug; 46(4):447-63. PubMed ID: 4879050
[No Abstract] [Full Text] [Related]
22. Genetically modified Bifidobacterium displaying Salmonella-antigen protects mice from lethal challenge of Salmonella Typhimurium in a murine typhoid fever model.
Yamamoto S; Wada J; Katayama T; Jikimoto T; Nakamura M; Kinoshita S; Lee KM; Kawabata M; Shirakawa T
Vaccine; 2010 Sep; 28(41):6684-91. PubMed ID: 20709009
[TBL] [Abstract][Full Text] [Related]
23. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
[TBL] [Abstract][Full Text] [Related]
24. Protective capacity of L-form Salmonella typhimurium against murine typhoid in C3H/HeJ mice.
Nishikawa F; Kita E; Yamada H; Nakano A; Kashiba S
Microbiol Immunol; 1994; 38(2):129-37. PubMed ID: 8041300
[TBL] [Abstract][Full Text] [Related]
25. THE BASIS FOR IMMUNITY TO MOUSE TYPHOID. 2. ANTIBODY FORMATION DURING THE CARRIER STATE.
TURNER KJ; JENKIN CR; ROWLEY D
Aust J Exp Biol Med Sci; 1964 Apr; 42():229-36. PubMed ID: 14150757
[No Abstract] [Full Text] [Related]
26. Histochemical studies on experimental typhoid by means of fluorescein-labeled antibody. II. Cellular localization of the antigens of Salmonella enteritidis in the process of the infection of experimental typhoid.
TANAKA N; NISHIMURA T; YAMAGUCHI H; YOSHIYUKI T
Jpn J Microbiol; 1960 Jan; 4():35-41. PubMed ID: 13775145
[No Abstract] [Full Text] [Related]
27. [Immunity in typhoid fever. II. Antigens and immune response in systemic salmonellosis].
Milhomem AM; Suassuna I
Mem Inst Oswaldo Cruz; 1982; 77(4):453-83. PubMed ID: 6764521
[No Abstract] [Full Text] [Related]
28. [The protective activity of different antigenic complexes of typhoid vaccine and prospects for improvement of chemical vaccines].
Kheĭfetz LB; Levina LA; Bentsianova TG; Salmin LV
Zh Mikrobiol Epidemiol Immunobiol; 1970 May; 47(5):89-96. PubMed ID: 5455485
[No Abstract] [Full Text] [Related]
29. Some regularities of antibody formation in mice immunized by salmonella cell fractions.
Stanislavsky ES; Fish NG; Balayan VD
J Hyg Epidemiol Microbiol Immunol; 1971; 15(1):9-22. PubMed ID: 4928824
[No Abstract] [Full Text] [Related]
30. [Properdin level and antibody production in the rabbit during immunization with Mycobacterium tuberculosis and Salmonella typhosa].
HEYMANN G; WAHLIG H
Z Immun exp ther; 1959 Jul; 118():57-72. PubMed ID: 14401639
[No Abstract] [Full Text] [Related]
31. Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines.
Zuckerman JN; Hatz C; Kantele A
Expert Rev Vaccines; 2017 Oct; 16(10):1029-1043. PubMed ID: 28856924
[TBL] [Abstract][Full Text] [Related]
32. Two types of immunity in experimental typhoid; "cellular immunity" and "humoral immunity".
Ushiba D
Keio J Med; 1965 Jun; 14(2):45-61. PubMed ID: 5827250
[No Abstract] [Full Text] [Related]
33. Efficient vaccination strategy against typhoid fever.
Arya SC
Vaccine; 2000 May; 18(22):2321-2. PubMed ID: 10905949
[No Abstract] [Full Text] [Related]
34. Antibody response to the protein antigens of "Salmonella typhi" during typhoid infection and following vaccination with a live oral typhoid vaccine Ty21a.
Chau PY; Tsang RS
Dev Biol Stand; 1983; 53():29-31. PubMed ID: 6873471
[TBL] [Abstract][Full Text] [Related]
35. [The antigenic structure of S-R-forms of salmonellae].
Stepanova LK; Sergeeva NS; Uvarova RN
Zh Mikrobiol Epidemiol Immunobiol; 1970 Mar; 47(3):14-9. PubMed ID: 4924154
[No Abstract] [Full Text] [Related]
36. [Formation of immunity to typhoid following immunization with alcoholic typho-paratyphoid B divaccine].
Pinegin BV
Zh Mikrobiol Epidemiol Immunobiol; 1966 Jun; 43(6):23-6. PubMed ID: 6004904
[No Abstract] [Full Text] [Related]
37. Monoclonal antibodies to Salmonella lipopolysaccharide: anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium.
Colwell DE; Michalek SM; Briles DE; Jirillo E; McGhee JR
J Immunol; 1984 Aug; 133(2):950-7. PubMed ID: 6203984
[TBL] [Abstract][Full Text] [Related]
38. Histochemical studies on experimental typhoid by means of fluorescein-labeled antibody. I. Cellular localization of the antigens of Salmonella enteritidis after injection of the killed vaccines.
TANAKA N; NISHIMURA T; YOSHIYUKI T
Jpn J Microbiol; 1959 Jul; 3():267-76. PubMed ID: 13836803
[No Abstract] [Full Text] [Related]
39. Multicenter study for the evaluation of the antibody response against salmonella typhi Vi vaccination (EMPATHY) for the diagnosis of Anti-polysaccharide antibody production deficiency in patients with primary immunodeficiency.
Sánchez-Ramón S; de Gracia J; García-Alonso AM; Rodríguez Molina JJ; Melero J; de Andrés A; García Ruiz de Morales JM; Ferreira A; Ocejo-Vinyals JG; Cid JJ; García Martínez JM; Lasheras T; Vargas ML; Gil-Herrera J; García Rodríguez MC; Castañer JL; González Granado LI; Allende LM; Soler-Palacin P; Herráiz L; López Hoyos M; Bellón JM; Silva G; Gurbindo DM; Carbone J; Rodríguez-Sáinz C; Matamoros N; Parker AR; Fernández-Cruz E;
Clin Immunol; 2016 Aug; 169():80-84. PubMed ID: 27236002
[No Abstract] [Full Text] [Related]
40. [Investigation on complement titer in focal diseases of the eye before and after typhoid vaccine therapy].
HUSZCZA A
Klin Oczna; 1955; 25(2):113-22. PubMed ID: 13252831
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
